Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Clinical trial NCT06228482 · RECRUITING

Trial details

NCT number: NCT06228482
Sponsor: University of California, Davis
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Nonsmall Cell Lung Cancer

Start date: 2024-01-22
Primary completion: 2027-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.